Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 22, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
$182.50 | -$2,925,000.00 |
—
| 73.44K |
Aug 20
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$177.50 | -$2,802,380.00 |
—
| 73.44K |
Aug 1
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| -7.09K |
$261.00 | -$1,851,273.00 | -8.81% | 73.44K |
Jul 11
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 8.65K |
$230.99 | -$1,917,475.08 | +12.04% | 80.53K |
Jun 24 - Jun 25
| |||||||
Alnylam Pharmaceuticals, Inc.
| 23.75K |
—
|
—
| +49.36% | 71.88K |
Mar 1
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.99K |
$155.31 | -$455,357.07 | +6.62% | 48.13K |
Feb 27 - Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| 9.92K |
$148.06 | -$1,040,884.56 | +28.18% | 45.14K |
Feb 15 - Feb 16
| |||||||
Alnylam Pharmaceuticals, Inc.
| 4.88K |
$185.85 | -$753,986.38 | +16.10% | 35.22K |
Aug 3 - Aug 4
| |||||||
Alnylam Pharmaceuticals, Inc.
| 9.34K |
$194.59 | -$1,481,811.47 | +44.47% | 30.33K |
Apr 26 - Apr 27
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 27
| |||||||
Alnylam Pharmaceuticals, Inc.
| 7.09K |
$191.68 | -$1,150,438.83 | +51.02% | 21K |
Aug 3 - Aug 4
| |||||||
Pacira Biosciences, Inc.
| 1.16K |
—
|
—
| +9.60% | 13.25K |
Jun 8
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.88K |
$189.01 | -$479,699.01 | +26.12% | 13.9K |
Dec 21 - Dec 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$138.05 | -$6,468,501.60 |
—
| 11.02K |
Aug 6
|
Scheduled
| ||||||
Pacira Biosciences, Inc.
| 1.07K |
—
|
—
| +9.67% | 12.09K |
Jun 9
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.73K |
$131.85 | -$309,977.15 | +32.95% | 11.02K |
Apr 19 - Apr 20
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 24
| |||||||
Alnylam Pharmaceuticals, Inc.
| 3.47K |
$155.99 | -$303,403.05 | +72.01% | 8.29K |
Feb 11 - Feb 12
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$101.61 | -$371,187.50 |
—
| 4.82K |
Jan 12
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$119.05 | -$3,913,012.10 |
—
| 4.82K |
Jul 10
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$102.07 | -$1,324,252.72 |
—
| 4.82K |
Jul 9
|
Scheduled
| ||||||
Pacira Biosciences, Inc.
| 1.26K |
—
|
—
| +12.91% | 11.02K |
Jun 9
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$110.52 | -$4,408,759.58 |
—
| 4.82K |
May 5 - May 6
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.9K |
$104.86 | -$263,503.31 | +151.57% | 4.82K |
Apr 7
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 26
| |||||||
Alnylam Pharmaceuticals, Inc.
| -4.29K |
$84.93 | -$1,560,028.00 | -69.14% | 1.92K |
Feb 7 - Feb 10
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 23
| |||||||
Alnylam Pharmaceuticals, Inc.
| 4.29K |
$120.61 | -$386,916.88 | +224.01% | 6.21K |
Dec 12
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$73.61 | -$527,603.12 |
—
| 1.92K |
Nov 20
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 50 |
—
|
—
| +14.01% | 407 |
Jul 11 - Aug 6
| |||||||
Alnylam Pharmaceuticals, Inc.
| 49 |
—
|
—
| +15.91% | 357 |
Apr 9 - Jun 5
| |||||||
Pacira Biosciences, Inc.
| 4.13K |
—
|
—
| +73.47% | 9.76K |
Jun 5
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 28
| ||||||
Moelis & Co
| 33.82 |
—
|
—
| +1.17% | 2.92K |
Nov 14
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Sep 27
| ||||||
Moelis & Co
| 111.57 |
—
|
—
| +3.57% | 3.24K |
Sep 12
| |||||||
Alnylam Pharmaceuticals, Inc.
| -2.50K |
$120.00 | -$300,000.00 | -56.61% | 1.92K | +1 |
Aug 30
|
Scheduled
| |||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.